| Literature DB >> 31463284 |
Anita Rawat1, Anil Kumar Gangwar2, Sunita Tiwari2, Surya Kant3, Ravindra Kumar Garg4, Prithvi Kumar Singh5.
Abstract
BACKGROUND: Studies have shown that alterations in the sleep cycle can predispose to several disorders. Most of the previous studies were done on the adults. Hence, the aim of the study was to see the effect of circadian disruption on the health of adolescent population.Entities:
Keywords: Daytime sleepiness; insulin resistance; morningness–eveningness; sleep quality
Year: 2019 PMID: 31463284 PMCID: PMC6691405 DOI: 10.4103/jfmpc.jfmpc_400_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Comparison of mean value of demographic factors, sleep quality, 2 h postprandial blood glucose level, insulin resistance, and daytime sleepiness of study subjects
| Group 1 ( | Group 2 ( | Group 3 ( | ||
|---|---|---|---|---|
| Age (years) | 18.21±0.67 | 18.90±0.68 | 18.05±0.65 | 0.395 |
| Sex | ||||
| Male | 47 (64.38%) | 57 (65.52%) | 27 (62.79%) | 0.9538 |
| Female | 26 (35.62%) | 30 (34.48%) | 16 (37.21%) | |
| Weight (kg) | 64.49±8.53 | 63.62±8.35 | 61.95±8.30 | 0.293 |
| Height (cm) | 167.27±8.17 | 168.02±8.17 | 168.21±8.57 | 0.793 |
| BMI | 23.06±2.45 | 22.50±2.15 | 21.89±2.27 | 0.029* |
| Neck circumference (cm) | 37.41±2.40 | 37.47±2.36 | 37.30±2.58 | 0.933 |
| Sleep quality | ||||
| Good | 7 (9.6%) | 19 (21.84%) | 26 (60.46%) | <0.001** |
| Poor | 66 (90.4%) | 68 (78.16%) | 17 (39.54%) | |
| Sleep duration (h) | ||||
| ≥7 | 8 (10.99%) | 10 (11.5%) | 10 (23.25%) | <0.001** |
| 6-7 | 15 (20.55%) | 16 (18.4%) | 25 (58.14%) | |
| <6 | 50 (68.5%) | 61 (70.1%) | 8 (18.6%) | |
| OGTT | ||||
| 2 h blood glucose (mg/dL) | 131.84±8.24 | 124.61±9.23 | 126.62±8.23 | <0.001** |
| HOMA | ||||
| Fasting glucose (mmol/L) | 5.63±0.48 | 5.40±0.55 | 5.21±0.58 | <0.001** |
| Fasting insulin (µIU/L) | 11.50±5.42 | 11.04±6.29 | 9.29±5.09 | 0.126 |
| HOMA-IR | 2.97±1.51 | 2.76±1.75 | 2.19±1.28 | 0.038* |
| ESS | 8.84±4.31 | 7.13±3.76 | 5.05±1.50 | <0.001** |
Data are represented as mean±SD, n (%) and ratio. BMI=body mass index; OGTT=oral glucose tolerance test; HOMA-IR=homeostasis model of assessment for insulin resistance; ESS=Epworth Sleepiness Score; SD=standard deviation. **P<0.001; *P<0.05
Crude OR of fasting blood glucose, 2 h postprandial blood glucose level, and HOMA-IR for poor sleep quality
| Poor sleep quality Frequency | OR (CI) | ||
|---|---|---|---|
| Blood glucose (fasting), mg/dL | |||
| ≤100 | 24 (22.64%) | 1 | - |
| >100 | 93 (95.88%) | 0.033 (0.01-0.11) | <0.001** |
| Blood glucose (2 h postprandial), mg/dL | |||
| ≤140 | 105 (55.56%) | 1 | - |
| >140 | 12 (85.71%) | 1.601 (0.17-15.57) | 0.0658 |
| HOMA-IR | |||
| ≤2.5 | 21 (22.11%) | 1 | - |
| >2.5 | 96 (88.89%) | 0.159 (0.06-0.42) | <0.001** |
OR=odds ratios; HOMA-IR=homeostasis model of assessment for insulin resistance; CI=confidence interval. **P<0.001
Correlation of body mass index and metabolic parameters with poor sleep quality in subjects of groups 1, 2, and 3
| Group 1 (Karl Pearson’s correlation coefficient) | Group 2 (Karl Pearson’s correlation coefficient) | Group 3 (Karl Pearson’s correlation coefficient) | |
|---|---|---|---|
| BMI | 0.479** | 0.552** | 0.638** |
| OGTT | |||
| Blood glucose (2 h) | 0.280* | 0.226* | 0.130 |
| HOMA | |||
| Fasting glucose (mmol/L) | 0.423** | 0.222 | 0.214 |
| Fasting Insulin (µIU/L) | 0.518** | 0.279* | 0.205 |
| HOMA-IR | 0.514** | 0.301* | 0.222 |
BMI=body mass index; OGTT=oral glucose tolerance test; HOMA-IR=homeostasis model of assessment for insulin resistance. **Correlation is significant at the 0.01 level (two-tailed); *correlation is significant at the 0.05 level (two-tailed)